Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome

K. Kobayashi, Y. Nishimura, T. Shimada, T. Takeda, H. Kamiryo, R. Matsuoka, K. Takenaka, D. Kasai, Y. Urata, T. Nishiuma, M. Satouchi, M. Yokoyama (Kobe, Japan)

Source: Annual Congress 2004 - Cardiovascular and metabolic consequences of OSA
Session: Cardiovascular and metabolic consequences of OSA
Session type: Thematic Poster Session
Number: 2094
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Kobayashi, Y. Nishimura, T. Shimada, T. Takeda, H. Kamiryo, R. Matsuoka, K. Takenaka, D. Kasai, Y. Urata, T. Nishiuma, M. Satouchi, M. Yokoyama (Kobe, Japan). Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Eur Respir J 2004; 24: Suppl. 48, 2094

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009


Bronchial reactivity in patients with obstructive sleep apnea syndrome treated with continuous positive airway pressure
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005

Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Amelioration of immune system activation in obstructive sleep apnea syndrome patients after continuous positive airway pressure treatment
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008

Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea
Source: Eur Respir J 2008; 32: 1009-1015
Year: 2008



Effect and significance of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003


Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006

Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients
Source: International Congress 2017 – CPAP therapy
Year: 2017


Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005

Predictors of continuous positive airway pressure adherence in obstructive sleep apnea syndrome
Source: International Congress 2017 – Inhalers and their use
Year: 2017


Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001



Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010


Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Humidified nasal continuous positive airway pressure in obstructive sleep apnoea
Source: Eur Respir J 2003; 22: 258-262
Year: 2003



Continuous positive airway pressure in patients with obstructive sleep apnea: Age-dependent adherence
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010


Titration of continuous positive airway pressure in Chinese patients with obstructive sleep apnea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Source: Eur Respir J 2007; 30: 496-500
Year: 2007



Evaluation of continuous positive airway pressure compliance in a group of obstructive sleep apnea patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012